The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
cis/trans-(S)-2-((S)-2-((S)-3-(4-aminocyclohexyl)-2-(2-phenylacetamido)propanamido)-3-hydroxypropanamido)-5-guanidinopentanamide ID: ALA2171750
PubChem CID: 71455265
Max Phase: Preclinical
Molecular Formula: C26H42N8O5
Molecular Weight: 546.67
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1CCC(N)CC1)NC(=O)Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C26H42N8O5/c27-18-10-8-17(9-11-18)13-20(32-22(36)14-16-5-2-1-3-6-16)24(38)34-21(15-35)25(39)33-19(23(28)37)7-4-12-31-26(29)30/h1-3,5-6,17-21,35H,4,7-15,27H2,(H2,28,37)(H,32,36)(H,33,39)(H,34,38)(H4,29,30,31)/t17?,18?,19-,20-,21-/m0/s1
Standard InChI Key: ZIRFNYRYJIRNHK-IMPXWGQXSA-N
Molfile:
RDKit 2D
39 40 0 0 0 0 0 0 0 0999 V2000
24.3326 -5.1291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0449 -5.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3216 -6.7815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.0394 -6.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7628 -5.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4751 -5.5554 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2997 -10.0904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5819 -10.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8654 -10.0809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5764 -11.3259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7518 -6.7910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7463 -7.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1807 -7.6287 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4586 -8.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0286 -8.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0231 -8.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3052 -9.2621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4532 -8.8643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0421 -1.8316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0409 -2.6580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7549 -3.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4706 -2.6576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4678 -1.8279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7531 -1.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1850 -3.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1863 -3.8926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9006 -4.3035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4732 -4.3057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9019 -5.1276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6163 -5.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1889 -5.5408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1902 -6.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4765 -6.7775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4758 -7.5980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1884 -8.0128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9032 -7.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9056 -6.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1866 -8.8369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6176 -6.3627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4 11 1 0
14 18 1 0
1 2 1 0
2 4 1 0
4 3 2 0
2 5 1 1
5 6 1 0
7 8 1 0
8 9 1 0
8 10 2 0
11 12 1 0
12 14 1 0
14 13 2 0
12 15 1 6
15 16 1 0
16 17 1 0
17 7 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
27 29 1 0
29 30 1 0
29 31 1 6
31 32 1 0
32 33 1 0
32 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
35 38 1 0
30 39 2 0
30 1 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 546.67Molecular Weight (Monoisotopic): 546.3278AlogP: -1.67#Rotatable Bonds: 15Polar Surface Area: 238.54Molecular Species: BASEHBA: 7HBD: 9#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.91CX Basic pKa: 11.69CX LogP: -2.60CX LogD: -7.29Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.07Np Likeness Score: 0.07
References 1. Caliendo G, Santagada V, Perissutti E, Severino B, Fiorino F, Frecentese F, Juliano L.. (2012) Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development., 55 (15): [PMID:22607152 ] [10.1021/jm300407t ]